People for the Ethical Treatment of Animals (PETA) is applying pressure to the nominee for commissioner of the US Food and Drug Administration, Martin Makary, to reverse the agency’s position on animal testing for sunscreens, while bringing more attention to the issue ahead of his confirmation hearing in March.
PETA Urges FDA Commissioner Nominee To Reverse Agency Position On Animal Testing
People for the Ethical Treatment of Animals will remove all non-mineral sunscreens from its Beauty Without Bunnies database in response to a statement FDA made publicly about the continued need for animal testing for sunscreens.

More from Policy & Regulation
Single-use packaging producers subject to California’s SB 54 recycling law, which implements a statewide EPR plan, should continue to prepare for its implementation, even as they enter a ‘prolonged period of uncertainty,’ says consultant Michael Washburn.
Data from the US Food and Drug Administration indicated that two hair dye ingredients are formulated in eye makeup and dermal application products, prompting a Cosmetic Ingredient Review panel to conclude one dye is unsafe for such uses and discouraging those uses in the other dye.
Preliminary registration data released by FDA offers a first glimpse of the Modernization of Cosmetics Regulation Act’s impact on information the agency has at hand.
Counterfeit beauty products cost the US industry an estimated $3bn in 2023, says a trade expert during the Personal Care Products Council’s Beauty Collective Summit.
More from HBW Insight
Vitawell seeking to empower consumers left confused by the vast array of dietary supplements available to them in the UK.
Tariffs on imports from China and look at eliminating self-affirmed GRAS pathway introduced under Trump while DoJ Consumer Protection Branch also continues supplement sector priorities enduring across administrations.
Round up of the latest appointments: PAGB names vice presidents; Activ'Inside gets first US head; EMA elects management board chair.